IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

IGF::OT::IGF R

• 批准号: 9355301
• 负责人: NALIN KUMAR
• 金额: $ 75万
• 依托单位: UHV TECHNOLOGIES, INC.
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-15 至 2017-09-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9355301
• 关键词: Applied Research; Collaborations; Contracts; Development; Drug Industry; Equipment; Excision; Goals; Laboratories; Measures; Medical; Metals; Monitor; Performance; Pharmacologic Substance; Phase; Process; Reaction; Small Business Innovation Research Grant; Vendor; base; design; field study; instrument; operation; prototype; research and development

The purpose of this SBIR Phase II contract is to develop an inexpensive and easy to use instrument that will be capable of measuring low ppm levels (at least <5 ppm) of a range of metals typically used in the pharmaceutical industry. The instrument would be co-located with the reaction and purification equipment where metal removal is performed, and preferably, amenable to continuous monitoring of metal impurities associated with continuous processing operations.

SBIR 第二阶段合同的目的是开发一种廉价且易于使用的仪器，该仪器将 能够测量制药中通常使用的一系列金属的低 ppm 水平（至少 <5 ppm） 行业。该仪器将与反应和纯化设备位于同一地点，其中金属去除 进行，并且优选地，能够连续监测与连续相关的金属杂质。 加工操作。